CAS 1648796-29-5

Gimsilumab

CAS : 1648796-29-5

Gimsilumab (MORAb-022) is an anti-c-Fms humanized monoclonal antibody for the study of inflammation and hypoxemia caused by COVID-19.

Degré de pureté : 99.49% (SEC-HPLC) - 99.49% (SEC-HPLC)

Couleur et forme : Transparent Liquid

Masse moléculaire : 145.8 kDa (Predicted)

Ref: TM-T77025

Gimsilumab

CAS : 1648796-29-5

Degré de pureté : 95%

Masse moléculaire : G/Mol

Ref: IN-DA02EOBS